Abstract
BACKGROUND:
Fatty liver disease (FLD) is characterized by increased intrahepatic triglyceride content with or without inflammation and is associated with obesity, and features of the metabolic syndrome. Several recent genome-wide association studies have reported an association between single-nucleotide polymorphism rs738409 in the (patatin-like phospholipase domain-containing protein 3) PNPLA3 gene and FLD. Liver attenuation (LA; hounsfield units, HU) by computed tomography is a non-invasive measure of liver fat, with lower values of HU indicating higher liver fat content. Clinically, a LA value of ⩽40 HU indicates moderate-to-severe hepatic steatosis.
OBJECTIVE:
We investigated whether missense rs738409 PNPLA3 interacted with abdominal visceral adipose tissue (VAT) volume (cm3) to reduce LA (that is, increased liver fat) in 1019 European American men and 1238 European American women from the Family Heart Study.
METHODS:
We used linear regression to test the additive effect of genotype, abdominal VAT, and their multiplicative interaction on LA adjusted for age, body mass index, high-density lipoprotein-cholesterol, insulin resistance, serum triglycerides, abdominal subcutaneous adipose tissue and alcohol intake.
RESULTS:
In men and women combined, the interaction between each copy of the rs738409 variant allele (minor allele frequency 0.23) and 100 cm3/150 mm slice VAT decreased LA by 2.68±0.35 HU (P<0.01). The interaction of 100 cm3 VAT and the variant allele was associated with a greater decrease in LA in women than men (−4.8±0.6 and −2.2±0.5 HU, respectively).
CONCLUSIONS:
The interaction between genotype and VAT volume suggest key differences in the role of PNPLA3 genotype in conjunction with abdominal VAT in liver fat accrual. The stronger association of the PNPLA3 genotype and liver fat in women suggests that women may be more sensitive to liver fat accumulation in the setting of increased visceral fat, compared with men. The presence of the PNPLA3 variant genotype, particularly in the context of high VAT content may have an important role in FLD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 2009; 52: 1056–1060.
Kotronen A, Vehkavaara S, Seppala-Lindroos A, Bergholm R, Yki-Jarvinen H . Effect of liver fat on insulin clearance. Am J Physiol Endocrinol Metab 2007; 293: E1709–E1715.
Brunt EM . Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010; 7: 195–203.
Byrne CD . Fatty liver: role of inflammation and fatty acid nutrition. Prostaglandins Leukot Essent Fatty Acids 2010; 82: 265–271.
Lewis JR, Mohanty SR . Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010; 55: 560–578.
Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ . Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450–455.
Sanyal AJ . Nonalcoholic fatty liver disease in the Indian subcontinent: a medical consequence of globalization? Indian J Gastroenterol 2001; 20: 215–216.
Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijarvi A et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 3023–3028.
Tiniakos DG, Vos MB, Brunt EM . Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010; 5: 145–171.
Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461–1465.
Stickel F, Buch S, Lau K, zu Schwabedissen HM, Berg T, Ridinger M et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology 2011; 53: 86–95.
Wagenknecht LE, Palmer ND, Bowden DW, Rotter JI, Norris JM, Ziegler J et al. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. Liver Int 2011; 31: 412–416.
Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD et al. Genome-wide association analysis identifies variants associated with nonalcoholic Fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011; 7: e1001324.
Guerrero R, Vega GL, Grundy SM, Browning JD . Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology 2009; 49: 791–801.
He S, McPhaul C, Li JZ, Garuti R, Kinch L, Grishin NV et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2010; 285: 6706–6715.
Hoekstra M, Li Z, Kruijt JK, Van Eck M, Van Berkel TJ, Kuiper J . The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status. J Hepatol 2010; 52: 244–251.
Davis JN, Le KA, Walker RW, Vikman S, Spruijt-Metz D, Weigensberg MJ et al. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr 2010; 92: 1522–1527.
Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol 2007; 22: 794–800.
Fan JG, Farrell GC . VAT fat is bad for the liver, SAT fat is not!. J Gastroenterol Hepatol 2008; 23: 829–832.
Hamdy O, Porramatikul S, Al-Ozairi E . Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006; 2: 367–373.
North KE, Graff M, Franceschini N, Reiner AP, Feitosa MF, Carr JJ et al. Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study. Eur J Gastroenterol Hepatol 2012; 24: 9–16.
Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR et al. NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996; 143: 1219–1228.
Carr JJ, Nelson JC, Wong ND, McNitt-Gray M, Arad Y, Jacobs DR et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005; 234: 35–43.
Sookoian S, Castano GO, Burgueno AL, Gianotti TF, Rosselli MS, Pirola CJ . A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 2009; 50: 2111–2116.
Farrell GC, Chitturi S, Lau GK, Sollano JD . Asia-Pacific Working Party on, N. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775–777.
Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007; 188: 1307–1312.
Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K et al. Abdominal fat: standardized technique for measurement at CT. Radiology 1999; 211: 283–286.
Center for Information Technology. MIPAV (Medical Image Processing, Analysis, and Visualization), vol. 2011. National Institutes of Health: Bethesda, 2007.
Wheeler GL, Shi R, Beck SR, Langefeld CD, Lenchik L, Wagenknecht LE et al. Pericardial and visceral adipose tissues measured volumetrically with computed tomography are highly associated in type 2 diabetic families. Invest Radiol 2005; 40: 97–101.
Warnick GR, Mayfield C, Benderson J, Chen JS, Albers JJ . HDL cholesterol quantitation by phosphotungstate-Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method. Am J Clin Pathol 1982; 78: 718–723.
Kraja AT, Hunt SC, Rao DC, Davila-Roman VG, Arnett DK, Province MA . Genetics of hypertension and cardiovascular disease and their interconnected pathways: lessons from large studies. Curr Hypertens Rep 2011; 13: 46–54.
Heath SC . Markov chain Monte Carlo segregation and linkage analysis for oligogenic models. Am J Hum Genet 1997; 61: 748–760.
Abecasis GR, Cherny SS, Cookson WO, Cardon LR . GRR: graphical representation of relationship errors. Bioinformatics 2001; 17: 742–743.
Huang Y, He S, Li JZ, Seo YK, Osborne TF, Cohen JC et al. A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc Natl Acad Sci USA 2010; 107: 7892–7897.
Larter CZ, Chitturi S, Heydet D, Farrell GC . A fresh look at NASH pathogenesis. Part 1: the metabolic movers. J Gastroenterol Hepatol 2010; 25: 672–690.
Farrell GC . PNPLeAse get the fats right: Does lipogenesis or lipolysis cause NASH? Hepatology 2011; 52: 819–821.
Gan SK, Kriketos AD, Poynten AM, Furler SM, Thompson CH, Kraegen EW et al. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res 2003; 11: 1295–1305.
Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007; 117: 2621–2637.
Demerath EW, Sun SS, Rogers N, Lee M, Reed D, Choh AC et al. Anatomical patterning of visceral adipose tissue: race, sex, and age variation. Obesity 2007; 15: 2984–2993.
Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J et al. Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr 2004; 80: 271–278.
Demerath EW, Reed D, Rogers N, Sun SS, Lee M, Choh AC et al. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr 2008; 88: 1263–1271.
Acknowledgements
We would like to thank Family Heart Study participants, collaborators and staff. This research is funded by a grant DK075681 (PI: IB Borecki) from the National Heart, Lung and Blood Institute. We would also like to acknowledge support of grant R01-HD057194 (from NICHD).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on International Journal of Obesity website
Supplementary information
Rights and permissions
About this article
Cite this article
Graff, M., North, K., Franceschini, N. et al. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: The NHLBI Family Heart Study. Int J Obes 37, 432–438 (2013). https://doi.org/10.1038/ijo.2012.65
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2012.65
Keywords
This article is cited by
-
Correlation between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction in non-obese adults: a cross-sectional study
BMC Gastroenterology (2023)
-
Non-communicable Diseases in Pregnant and Postpartum Women Living with HIV: Implications for Health Throughout the Life Course
Current HIV/AIDS Reports (2021)
-
NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?
Current HIV/AIDS Reports (2018)
-
The longitudinal effect of the aldehyde dehydrogenase 2*2 allele on the risk for nonalcoholic fatty liver disease
Nutrition & Diabetes (2016)
-
Risk Factors for Fatty Liver in the Multicenter AIDS Cohort Study
American Journal of Gastroenterology (2014)